Published in Contemp Clin Trials on November 11, 2011
Exercising Together: An Intervention for Prostate Cancer Survivors and Spouses | NCT00954044
Patterns and predictors of symptom incongruence in older couples coping with prostate cancer. Support Care Cancer (2013) 0.83
The effects of partnered exercise on physical intimacy in couples coping with prostate cancer. Health Psychol (2015) 0.78
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol (1994) 30.72
Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med (1995) 20.53
Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci (2000) 15.54
Can comorbidity be measured by questionnaire rather than medical record review? Med Care (1996) 10.53
Caregiving and the stress process: an overview of concepts and their measures. Gerontologist (1990) 9.73
Marriage and health: his and hers. Psychol Bull (2001) 9.47
Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc (2006) 8.75
American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc (1998) 8.55
CHAMPS physical activity questionnaire for older adults: outcomes for interventions. Med Sci Sports Exerc (2001) 7.96
Differences between caregivers and noncaregivers in psychological health and physical health: a meta-analysis. Psychol Aging (2003) 6.98
American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc (2010) 6.18
Is caregiving hazardous to one's physical health? A meta-analysis. Psychol Bull (2003) 5.55
Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res (1999) 4.38
Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol (2005) 4.10
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
American College of Sports Medicine Position Stand. Exercise and physical activity for older adults. Med Sci Sports Exerc (1998) 3.67
An evaluation of three self-report physical activity instruments for older adults. Med Sci Sports Exerc (2001) 3.54
Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev (2005) 3.34
The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum (1998) 2.92
A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med (2005) 2.85
Lower extremity performance in nondisabled older persons as a predictor of subsequent hospitalization. J Gerontol A Biol Sci Med Sci (2000) 2.81
Living with prostate cancer: patients' and spouses' psychosocial status and quality of life. J Clin Oncol (2007) 2.53
Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum (1997) 2.42
Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract (2002) 2.36
Mutuality and preparedness as predictors of caregiver role strain. Res Nurs Health (1990) 2.29
Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol (2001) 2.16
Prognostic importance of marital quality for survival of congestive heart failure. Am J Cardiol (2001) 1.96
Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol (2008) 1.96
Interventions for sarcopenia and muscle weakness in older people. Age Ageing (2004) 1.93
Exercise manages fatigue during breast cancer treatment: a randomized controlled trial. Psychooncology (2005) 1.89
Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. J Clin Oncol (2003) 1.89
Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA (2010) 1.83
Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum (1998) 1.81
Caregiving as a dyadic process: perspectives from caregiver and receiver. J Gerontol B Psychol Sci Soc Sci (2002) 1.76
A randomized controlled trial of high versus low intensity weight training versus general practitioner care for clinical depression in older adults. J Gerontol A Biol Sci Med Sci (2005) 1.74
Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol (Oxf) (2002) 1.64
Benefits of 2 years of intense exercise on bone density, physical fitness, and blood lipids in early postmenopausal osteopenic women: results of the Erlangen Fitness Osteoporosis Prevention Study (EFOPS). Arch Intern Med (2004) 1.51
Physical functioning of elderly cancer patients prior to diagnosis and following initial treatment. Nurs Res (2001) 1.48
Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer (2007) 1.47
Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. Oncol Nurs Forum (2000) 1.46
Musculoskeletal response to exercise is greatest in women with low initial values. Med Sci Sports Exerc (2003) 1.44
Weighted vest exercise improves indices of fall risk in older women. J Gerontol A Biol Sci Med Sci (1998) 1.37
Long-term exercise using weighted vests prevents hip bone loss in postmenopausal women. J Gerontol A Biol Sci Med Sci (2000) 1.35
Physical health and the onset and persistence of depression in older adults: an eight-wave prospective community-based study. Psychol Med (2000) 1.34
Strength training as a countermeasure to aging muscle and chronic disease. Sports Med (2011) 1.33
The relationship between marital quality and adherence to the diabetes care regimen. Ann Behav Med (2004) 1.31
Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol (2005) 1.30
Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc (2006) 1.25
Spousal responses to prostate cancer: an integrative review. Cancer Invest (2006) 1.16
Injuries during the one repetition maximum assessment in the elderly. J Cardiopulm Rehabil (1996) 1.10
Detraining reverses positive effects of exercise on the musculoskeletal system in premenopausal women. J Bone Miner Res (2000) 1.09
Effect of alendronate and exercise on bone and physical performance of postmenopausal women: a randomized controlled trial. Bone (2003) 1.09
Physical function in men with prostate cancer on androgen deprivation therapy. Phys Ther (2007) 1.06
Leisure-time exercise and overall physical activity in older women caregivers and non-caregivers from the Caregiver-SOF Study. Prev Med (2006) 1.06
Injuries and adherence to walk/jog and resistance training programs in the elderly. Med Sci Sports Exerc (1991) 1.06
Quality of life in prostate cancer patients taking androgen deprivation therapy. J Am Geriatr Soc (2006) 1.04
Physical functioning and depression among older persons with cancer. Cancer Pract (2002) 1.00
Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer. BJU Int (2007) 0.99
The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol (2001) 0.98
Differences in health-related quality of life of prostate cancer patients based on stage of cancer. Psychooncology (2004) 0.97
Use and perceived efficacy of self-care activities in patients receiving chemotherapy. Oncol Nurs Forum (1991) 0.94
Cancer-related communication between female patients and male partners scale: A pilot study. Psychooncology (2006) 0.93
Efficacy of a 24-week aerobic exercise program for osteopenic postmenopausal women. Calcif Tissue Int (2000) 0.90
Emotional congruence in older couples coping with wives' osteoarthritis: exacerbating effects of pain behavior. Psychol Aging (2003) 0.89
Caregiving and institutionalization: perceptions of family conflict and socioemotional support. Int J Aging Hum Dev (1999) 0.88
Concerns, affect, and cognitive disruption following completion of radiation treatment for localized breast or prostate cancer. Oncol Nurs Forum (1996) 0.84
Factors affecting bone mineral density in patients with prostate carcinoma before and after orchidectomy. Cancer (2005) 0.82
Emotional and physical intimacy in coping with lupus: women's dilemmas of disclosure and approach. Health Psychol (1997) 0.82
Effect of increased physical activity on bone mineral density in postmenopausal osteoporotic women. Keio J Med (1998) 0.76
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol (2008) 18.54
Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science (2009) 13.87
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study. Lancet (2010) 10.79
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med (2012) 3.21
How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol (2004) 2.92
A molecular correlate to the Gleason grading system for prostate adenocarcinoma. Proc Natl Acad Sci U S A (2006) 2.89
Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer. Cancer Res (2010) 2.42
New therapies for castration-resistant prostate cancer: efficacy and safety. Eur Urol (2011) 2.21
Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer. J Urol (2006) 1.98
Statins and prostate cancer risk: a case-control study. Am J Epidemiol (2005) 1.90
Improved detection of prostate cancer using classification and regression tree analysis. J Clin Oncol (2005) 1.85
T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors. Clin Cancer Res (2003) 1.79
Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage (2006) 1.78
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. J Urol (2007) 1.75
Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology (2006) 1.75
Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials. Eur Urol (2012) 1.64
Phase II study of transdermal estradiol in androgen-independent prostate carcinoma. Cancer (2005) 1.49
A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma. Sci Transl Med (2011) 1.48
Advanced penile carcinoma. J Urol (2003) 1.47
Interest in physician-assisted suicide among Oregon cancer patients. J Clin Ethics (2006) 1.45
American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer. J Clin Oncol (2007) 1.41
Treatment of Nonmetastatic Castration-Resistant Prostate Cancer. Oncology (Williston Park) (2016) 1.38
Motivational interviewing to increase physical activity in long-term cancer survivors: a randomized controlled trial. Nurs Res (2006) 1.38
The cancer chemotherapy drug etoposide (VP-16) induces proinflammatory cytokine production and sickness behavior-like symptoms in a mouse model of cancer chemotherapy-related symptoms. Biol Res Nurs (2006) 1.37
Outcomes of clinical trial: tinnitus masking versus tinnitus retraining therapy. J Am Acad Audiol (2006) 1.34
Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group. J Clin Oncol (2007) 1.32
Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer. Clin Cancer Res (2009) 1.29
Measurement of fatigue. determining minimally important clinical differences. J Clin Epidemiol (2002) 1.25
HDAC4 protein regulates HIF1α protein lysine acetylation and cancer cell response to hypoxia. J Biol Chem (2011) 1.25
Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines. Oncol Nurs Forum (2006) 1.22
Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research. Clin Genitourin Cancer (2009) 1.17
CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity. Prostate (2010) 1.14
Development and initial testing of a measure of person-directed care. Gerontologist (2008) 1.12
Shed membrane fragment-associated markers for endometrial and ovarian cancers. Gynecol Oncol (2002) 1.11
A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel. Cancer (2008) 1.10
Do motor and nonmotor symptoms in PD patients predict caregiver strain and depression? Mov Disord (2008) 1.09
Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer. Cancer (2008) 1.08
Frailty in older breast cancer survivors: age, prevalence, and associated factors. Oncol Nurs Forum (2013) 1.07
The effect of resistance training on muscle strength and physical function in older, postmenopausal breast cancer survivors: a randomized controlled trial. J Cancer Surviv (2011) 1.07
Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med (2014) 1.04
C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results. Urol Oncol (2010) 1.02
The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells. Clin Cancer Res (2008) 1.01
A telephone-only motivational intervention to increase physical activity in rural adults: a randomized controlled trial. Nurs Res (2007) 1.01
ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21. Cancer Res (2010) 1.01
Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15. Clin Cancer Res (2007) 1.00
Prostate cancer survival is dependent on season of diagnosis. Prostate (2007) 0.99
A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer. Urol Oncol (2011) 0.99
Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection. Magn Reson Med (2012) 0.96
HIF1α protein stability is increased by acetylation at lysine 709. J Biol Chem (2012) 0.96
In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors. Clin Cancer Res (2005) 0.95
Does age make a difference in caregiver strain? Comparison of young versus older caregivers in early-stage Parkinson's disease. Mov Disord (2010) 0.94
A community-based participatory research approach to understanding pap testing adherence among Vietnamese American immigrants. J Obstet Gynecol Neonatal Nurs (2012) 0.93
Sustained complete response to CTLA-4 blockade in a patient with metastatic, castration-resistant prostate cancer. Cancer Immunol Res (2014) 0.93
Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer. Urol Oncol (2006) 0.93
A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancer. Int J Radiat Oncol Biol Phys (2003) 0.93
Explaining family caregiver role strain following autologous blood and marrow transplantation. J Psychosoc Oncol (2006) 0.92
A review of exercise interventions to improve bone health in adult cancer survivors. J Cancer Surviv (2010) 0.92
A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer. Invest New Drugs (2014) 0.92
Androgen deprivation impairs memory in older men. Behav Neurosci (2005) 0.91
Cell membrane water exchange effects in prostate DCE-MRI. J Magn Reson (2012) 0.91
Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men. Cancer Causes Control (2010) 0.91
Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer. BJU Int (2005) 0.88
Malate dehydrogenase 2 confers docetaxel resistance via regulations of JNK signaling and oxidative metabolism. Prostate (2013) 0.88
Assessment of prostate-specific antigen doubling time in prediction of prostate cancer on needle biopsy. Urology (2007) 0.88
Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer. J Lipid Res (2005) 0.88
Skeletal response to resistance and impact training in prostate cancer survivors. Med Sci Sports Exerc (2014) 0.86
Incorporating routine survival prediction in a U.S. hospital-based palliative care service. J Palliat Med (2010) 0.86
Validity and reliability of the European Heart Failure Self-care Behavior Scale among adults from the United States with symptomatic heart failure. Eur J Cardiovasc Nurs (2012) 0.86
Views on physician-assisted suicide among family members of Oregon cancer patients. J Pain Symptom Manage (2006) 0.86
Operationalizing symptom distress in adults with cancer: a literature synthesis. Oncol Nurs Forum (2005) 0.86
Polymorphisms of GSTT1 and related genes in head and neck cancer risk. Head Neck (2004) 0.86
Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer. Cancer (2010) 0.85
Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer. Clin Genitourin Cancer (2012) 0.85
Poststroke depression: social workers' role in addressing an underrecognized psychological problem for couples who have experienced stroke. Health Soc Work (2011) 0.85
Definitions of sedentary in physical-activity-intervention trials: a summary of the literature. J Aging Phys Act (2006) 0.84
The medical management of prostate cancer: a multidisciplinary team approach. BJU Int (2006) 0.84
Patterns and predictors of symptom incongruence in older couples coping with prostate cancer. Support Care Cancer (2013) 0.83
Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer. Cancer (2007) 0.83
Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy. Urology (2007) 0.83
Prostate cancer-associated gene expression alterations determined from needle biopsies. Clin Cancer Res (2009) 0.83
Histologic changes associated with neoadjuvant chemotherapy are predictive of nodal metastases in patients with high-risk prostate cancer. Am J Clin Pathol (2010) 0.83
Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer. Clin Cancer Res (2013) 0.83
Experimental use of GnRH antagonists as second-line hormonal therapy. Rev Urol (2004) 0.82
High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II study. J Urol (2005) 0.82
The association of bone mineral density with prostate cancer risk in the Osteoporotic Fractures in Men (MrOS) Study. Cancer Epidemiol Biomarkers Prev (2009) 0.81
Mammography decision making in older women with a breast cancer family history. J Nurs Scholarsh (2010) 0.81
A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer. BJU Int (2008) 0.81
Expanding poststroke depression research: movement toward a dyadic perspective. Top Stroke Rehabil (2011) 0.80
Parenteral estrogens for prostate cancer: can a new route of administration overcome old toxicities? Clin Genitourin Cancer (2006) 0.80
Classification and regression tree analysis for the prediction of aggressive prostate cancer on biopsy. J Urol (2006) 0.80
Pharmacotherapeutic management of metastatic, castration-resistant prostate cancer in the elderly: focus on non-chemotherapy agents. Drugs Aging (2014) 0.80
Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer. Cancer Chemother Pharmacol (2003) 0.79
Prostate cancer and vitamin D: what does the evidence really suggest? Urol Clin North Am (2011) 0.79